Does identifying an increased risk based on genetic profiling lead to preventive measures that can reduce a person's risk for developing disease or to improve disease outcome? This webcast explores the public's understanding and perceptions of genetic testing and what is really useful in the day-to-day healthcare management from the physician-patient perspective.
Advertisement
Penn researchers, in collaboration with the Coriell Institute, will present new research that reports the attitudes and motivations of early seekers of personalized genetic information, as well as hear from study participants themselves and a panel of experts covering the many aspects of genetic profiling.
Advertisement
WHAT:
Please join us for a writers' roundtable to discuss these issues with study participants, and from a clinician, genetic counseling, and bioethics perspective.
WHO:
Roundtable Participants
WHEN:
Wednesday, May 19, 2010: 8:30 a.m. - 11:00 a.m.
Discussion begins at 8:45 a.m. Coffee and light refreshments offered at the start of the roundtable.
WHERE:
Live streaming video webcast..
In Person: Biomedical Research Building, Room 253
421 Curie Blvd, Philadelphia, PA 19104
http://www.med.upenn.edu/aging/documents/brbdirections.pdf
HOW:
Please register to attend in person by contacting Karen Kreeger at 215-349-5658 or [email protected]. Space is limited.
Media RSVPs for the webcast are also appreciated.
CONTACT: Karen Kreeger, +1-215-349-5658, [email protected]
/PRNewswire-USNewswire -- May 17/
-- Dan Rader, MD, professor of Medicine and Pharmacology and director, Preventive Cardiovascular Medicine and Lipid Clinic at Penn, will discuss how genetic information can be used from a patient-physician perspective, particularly in the management of heart failure. -- Art Caplan, Ph.D., director of the Center for Bioethics at Penn, will discuss how genetic information might be used, abused, or both. -- Barbara Bernhardt, MS, CGC, genetic counselor and clinical associate professor of Medicine in Medical Genetics at Penn; co-investigator on the Penn study, will discuss study participants' motivations for enrolling in the study and their attitudes toward their results. -- Michael F. Christman, Ph.D., president and CEO, Coriell Institute and principal investigator, CPMC, will talk about the overall CPMC study. -- Study participants will talk about what motivated them to participate in the study; how they might use their genetic information in the future to change their behavior; who they might share it with; and concerns about sharing it.
SOURCE Penn Medicine
